Emvenio Research
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
EmVenio Research, a PCM Trials company (rebranded as EmVenio Clinical Research in August 2025), provides a scalable network of clinical trial sites strategically located in underrepresented communities to engage diverse patient demographics. Its network of clinicians, principal investigators (averaging 14+ years of trial experience), and research sites supported more than 140 clinical trials for sponsors and CROs in 2025, prioritizing equitable access, retention, and representation.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Award and rebrand
EmVenio Research was named Best Clinical Research Company at the 2025 Vaccine Industry Excellence Awards, and in August 2025 PCM Trials consolidated itself with EmVenio Research and Clinical Trial Service under the EmVenio Clinical Research name.
- Chicago site
In November 2025, EmVenio Clinical Research opened a dedicated community research site at Chicago's Saint Mary of Nazareth Hospital in partnership with Prime Healthcare.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.